Numinus Wellness CEO Payton Nyquvest joined Steve Darling from Proactive to share news the company has finalized the study design and protocol for their Phase 1 clinical trial on a naturally derived Psilocybin extract.
Nyquvest telling Proactive the Phase I clinical trial will use both PSYBINA RX and the Psilocybin comparator and will be conducted at Numinus' clinical site in Vancouver, BC on 14 healthy volunteers.